DNA Damage, Mutagenesis and Cancer
暂无分享,去创建一个
[1] S. Hecht,et al. Tobacco smoke carcinogens and lung cancer. , 1999, Journal of the National Cancer Institute.
[2] Robert E. Johnson,et al. Response to Burgers et al. , 2016, Molecular cell.
[3] P. Karran,et al. DNA mismatch binding defects, DNA damage tolerance, and mutator phenotypes in human colorectal carcinoma cell lines. , 1995, Cancer research.
[4] W. Willett,et al. Diet and breast cancer , 2022, Nature.
[5] F. Crick,et al. The structure of DNA. , 1953, Cold Spring Harbor symposia on quantitative biology.
[6] B. Ames,et al. Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[7] C. Harris. Tumour suppressor genes, multistage carcinogenesis and molecular epidemiology. , 1992, IARC scientific publications.
[8] P. Hainaut,et al. On the origin of G --> T transversions in lung cancer. , 2003, Mutation research.
[9] D. Shibata,et al. p53 mutations and microsatellite instability in sporadic gastric cancer: when guardians fail. , 1994, Cancer research.
[10] Y Nishizuka,et al. Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. , 1982, The Journal of biological chemistry.
[11] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[12] T. Lindahl,et al. Suppression of spontaneous mutagenesis in human cells by DNA base excision-repair. , 2000, Mutation research.
[13] T. Sugimura,et al. New classes of tumor promoters: teleocidin, aplysiatoxin, and palytoxin. , 1987, Advances in cancer research.
[14] J. Miller,et al. A set of lacZ mutations in Escherichia coli that allow rapid detection of each of the six base substitutions. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[15] D. J. Ashley,et al. The two "hit" and multiple "hit" theories of carcinogenesis. , 1969, British Journal of Cancer.
[16] W. Willett,et al. Diet and cancer: one view at the start of the millennium. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[17] C. Ong,et al. Mutations of the p53 tumor suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis. , 1996, Mutation research.
[18] Nordling Co. A New Theory on the Cancer-inducing Mechanism , 1953 .
[19] B. Vogelstein,et al. A genetic model for colorectal tumorigenesis , 1990, Cell.
[20] P. Modrich. Mechanisms in E. coli and Human Mismatch Repair (Nobel Lecture). , 2016, Angewandte Chemie.
[21] J. DiGiovanni,et al. Comparison of the histological changes in the skin of DBA/2 and C57BL/6 mice following exposure to various promoting agents. , 1987, Carcinogenesis.
[22] E. Koonin,et al. Eukaryotic DNA Polymerases: Proposal for a Revised Nomenclature* , 2001, The Journal of Biological Chemistry.
[23] Y. Nakamura,et al. Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.
[24] I. Berenblum,et al. The Persistence of Latent Tumour Cells Induced in the Mouse's Skin by a Single Application of 9:10-Dimethyl-1:2-Benzanthracene , 1949, British Journal of Cancer.
[25] H. Ananthaswamy,et al. Mechanisms of induction of skin cancer by UV radiation. , 1997, Frontiers in bioscience : a journal and virtual library.
[26] G. Wogan. Aflatoxin as a human carcinogen , 1999, Hepatology.
[27] J. J. Freeman,et al. Short-term biomarkers of tumor promotion in mouse skin treated with petroleum middle distillates. , 1998, Toxicological sciences : an official journal of the Society of Toxicology.
[28] S. Rakoff-Nahoum,et al. Why Cancer and Inflammation? , 2006, The Yale journal of biology and medicine.
[29] L. Loeb,et al. Errors in DNA replication as a basis of malignant changes. , 1974, Cancer research.
[30] Jiri Bartek,et al. Cell-cycle checkpoints and cancer , 2004, Nature.
[31] L. Triplett,et al. Skin tumor-promoting activity of benzoyl peroxide, a widely used free radical-generating compound. , 1981, Science.
[32] M. Jackson,et al. Genetic pathways and mutation profiles of human cancers: site- and exposure-specific patterns. , 2007, Carcinogenesis.
[33] Thierry Soussi,et al. Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects , 1997, Nucleic Acids Res..
[34] R. Doll,et al. Etiology of lung cancer. , 1950, Advances in cancer research.
[35] K. Tang,et al. A Randomized Controlled Trial of Progressively Reduced Nicotine Content Cigarettes on Smoking Behaviors, Biomarkers of Exposure, and Subjective Ratings , 2016, Cancer Epidemiology, Biomarkers & Prevention.
[36] J. R. Brown,et al. Percivall Pott (1714-1788) and Chimney Sweepers' Cancer of the Scrotum , 1957, British journal of industrial medicine.
[37] C. Nordling. A New Theory on the Cancer-inducing Mechanism , 1953, British Journal of Cancer.
[38] Richard B. Hayes,et al. The carcinogenicity of metals in humans , 1997, Cancer Causes & Control.
[39] R. Doll,et al. Smoking and Carcinoma of the Lung , 1950, Acta - Unio Internationalis Contra Cancrum.
[40] A. Jemal,et al. Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.
[41] A. Basu. Mutagenesis: The Outcome of Faulty Replication of DNA , 2011 .
[42] D. Grunberger,et al. Molecular Biology of Mutagens and Carcinogens , 1983, Springer US.
[43] A L ABOUL-NASR,et al. Epidemiology of cancer. , 1957, The Journal of the Egyptian Medical Association.
[44] C. Harris,et al. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. , 1994, Cancer research.
[45] I. Jamall,et al. Somatic Mutation Theory - Why it's Wrong for Most Cancers , 2016, Cellular Physiology and Biochemistry.
[46] A. Robock,et al. Local nuclear war, global suffering. , 2010, Scientific American.
[47] R. Harvey,et al. Historical Overview of Chemical Carcinogenesis , 2011 .
[48] A. J. Varghese,et al. cis-syn Thymine Homodimer from Ultraviolet Irradiated Calf Thymus DNA , 1967, Nature.
[49] D. Hatsukami,et al. Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation. , 1999, Cancer research.
[50] A. Jackson,et al. The mutation rate and cancer. , 1998, Genetics.
[51] W. Burnett,et al. Angiosarcoma of the liver: an epidemiologic survey. , 1977, Journal of the National Cancer Institute.
[52] A. J. Varghese,et al. Concerning the mechanism of formation of uv-induced thymine photoproducts in DNA. , 1967, Proceedings of the National Academy of Sciences of the United States of America.
[53] I. MartínezMartínez. Epidemiology of Cancer , 1984 .
[54] M. Levin,et al. Cancer and tobacco smoking; a preliminary report. , 1950, Journal of the American Medical Association.
[55] R. Doll,et al. Smoking and carcinoma of the lung; preliminary report. , 1950, British medical journal.
[56] L. Naldi,et al. The epidemiology of skin cancer , 2002, The British journal of dermatology.
[57] H. Fujiki,et al. A rapid, simple screening method for skin-tumor promoters using mouse peritoneal macrophages in vitro. , 1984, Cancer letters.
[58] T. Kunkel,et al. The Y-family of DNA polymerases. , 2001, Molecular cell.
[59] K Yamagiwa,et al. Experimental study of the pathogenesis of carcinoma , 1977, CA: a cancer journal for clinicians.
[60] Rebecca L. Siegel Mph,et al. Cancer statistics, 2016 , 2016 .
[61] T. Kunkel,et al. Who Is Leading the Replication Fork, Pol ε or Pol δ? , 2016, Molecular cell.
[62] Z. Ronai,et al. G to A transitions and G to T transversions in codon 12 of the Ki-ras oncogene isolated from mouse lung tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and related DNA methylating and pyridyloxobutylating agents. , 1993, Carcinogenesis.
[63] W. Nicholson,et al. The carcinogenicity of chrysotile asbestos--a review. , 2001, Industrial health.
[64] J. DiGiovanni,et al. Multistage carcinogenesis in mouse skin. , 1992, Pharmacology & therapeutics.
[65] W. Halperin,et al. Notification and risk assessment for bladder cancer of a cohort exposed to aromatic amines. III. Mortality among workers exposed to aromatic amines in the last beta-naphthylamine manufacturing facility in the United States. , 1985, Journal of occupational medicine. : official publication of the Industrial Medical Association.
[66] H. Fujiki,et al. Tumor promoters: from chemicals to inflammatory proteins , 2013, Journal of Cancer Research and Clinical Oncology.
[67] T. Sugimura,et al. Indole alkaloids: dihydroteleocidin B, teleocidin, and lyngbyatoxin A as members of a new class of tumor promoters. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[68] A. Basu,et al. Mutagenicity of nitroaromatic compounds. , 2000, Chemical research in toxicology.
[69] D. Michaels,et al. When Science Isn't Enough: Wilhelm Hueper, Robert A. M. Case, and the Limits of Scientific Evidence in Preventing Occupational Bladder Cancer. , 1995, International journal of occupational and environmental health.
[70] B. Pullman,et al. Electronic structure and carcinogenic activity of aromatic molecules; new developments. , 1955, Advances in cancer research.
[71] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[72] R. Heidel,et al. Reducing the Health Consequences of Smoking: 25 Years of Progress. A Report of the Surgeon General. , 1989 .
[73] T. Slaga,et al. Promotion of carcinomas by repeated abrasion in initiated skin of mice. , 1981, Cancer research.
[74] W. Lutz,et al. Correlation of DNA adduct levels with tumor incidence: carcinogenic potency of DNA adducts. , 1999, Mutation research.
[75] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[76] S. Nesnow,et al. Murine susceptibility to two-stage skin carcinogenesis is influenced by the agent used for promotion. , 1984, Carcinogenesis.
[77] Th. Boveri. Concerning the Origin of Malignant Tumours by Theodor Boveri. Translated and annotated by Henry Harris , 2008, Journal of Cell Science.
[78] C. Kemp. Animal Models of Chemical Carcinogenesis: Driving Breakthroughs in Cancer Research for 100 Years. , 2015, Cold Spring Harbor protocols.
[79] E. Hecker. Phorbol esters from croton oil chemical nature and biological activities , 2004, The Science of Nature.
[80] J. Essigmann,et al. Site-specifically alkylated oligodeoxynucleotides: probes for mutagenesis, DNA repair and the structural effects of DNA damage. , 1990, Mutation research.
[81] O. Avery,et al. Studies on the Chemical Nature of the Substance Inducing Transformation of Pneumococcal Types : Induction of Transformation by a Desoxyribonucleic Acid Fraction Isolated from Pneumococcus Type III ” ( 1944 ) by , 2019 .
[82] P. Cerutti,et al. Aflatoxin B1 induces the transversion of G-->T in codon 249 of the p53 tumor suppressor gene in human hepatocytes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[83] R. Goldbohm,et al. Epidemiological studies on brassica vegetables and cancer risk. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[84] E. Birney,et al. Patterns of somatic mutation in human cancer genomes , 2007, Nature.
[85] Andrew Menzies,et al. Architectures of somatic genomic rearrangement in human cancer amplicons at sequence-level resolution. , 2007, Genome research.
[86] P. Hanawalt,et al. DNA repair: from molecular mechanism to human disease. , 2006, DNA repair.
[87] K. Kinzler,et al. Lessons from Hereditary Colorectal Cancer , 1996, Cell.
[88] M. Seidman,et al. Use of supF, an Escherichia coli tyrosine suppressor tRNA gene, as a mutagenic target in shuttle-vector plasmids. , 1989, Mutation research.
[89] Robert E. Johnson,et al. A Major Role of DNA Polymerase δ in Replication of Both the Leading and Lagging DNA Strands. , 2015, Molecular cell.
[90] L. Loeb,et al. Efficiency of carcinogenesis with and without a mutator mutation , 2006, Proceedings of the National Academy of Sciences.
[91] O. Avery,et al. STUDIES ON THE CHEMICAL NATURE OF THE SUBSTANCE INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES , 1944, The Journal of experimental medicine.
[92] K. Reynolds,et al. The Accuracy and Trends of Smoking History Documentation in Electronic Medical Records in a Large Managed Care Organization , 2013, Substance use & misuse.
[93] G. Spivak. Nucleotide excision repair in humans. , 2015, DNA repair.
[94] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[95] D. Clayson. Specific aromatic amines as occupational bladder carcinogens. , 1981, National Cancer Institute monograph.
[96] C. Sonnenschein,et al. The aging of the 2000 and 2011 Hallmarks of Cancer reviews: A critique , 2013, Journal of Biosciences.
[97] L. Loeb,et al. Environmental and chemical carcinogenesis. , 2004, Seminars in cancer biology.
[98] J. W. Cook,et al. 106. The isolation of a cancer-producing hydrocarbon from coal tar. Parts I, II, and III , 1933 .
[99] D. Clive,et al. Validation and characterization of the L5178Y/TK+/- mouse lymphoma mutagen assay system. , 1979, Mutation research.
[100] G. Wolf,et al. Metabolism of polycyclic compounds. 6. Conversion of phenanthrene into dihydroxydihydrophenanthrenes. , 1950, The Biochemical journal.
[101] T. Santonen,et al. Diesel Engine Exhaust: Basis for Occupational Exposure Limit Value. , 2017, Toxicological sciences : an official journal of the Society of Toxicology.
[102] A. J. Varghese,et al. Ultraviolet Irradiation of DNA in vitro and in vivo Produces a Third Thymine-Derived Product , 1967, Science.
[103] A. Jemal,et al. Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.
[104] A. J. Varghese,et al. Cytosine-thymine addition product from DNA irradiated with ultraviolet light. , 1967, Biochemical and biophysical research communications.
[105] A. Knudson. Hereditary cancer: Two hits revisited , 2005, Journal of Cancer Research and Clinical Oncology.